These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34779913)

  • 1. GLI1-altered mesenchymal tumor: a clinicopathological and molecular analysis of ten additional cases of an emerging entity.
    Liu J; Mao R; Lao IW; Yu L; Bai Q; Zhou X; Wang J
    Virchows Arch; 2022 May; 480(5):1087-1099. PubMed ID: 34779913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions.
    Antonescu CR; Agaram NP; Sung YS; Zhang L; Swanson D; Dickson BC
    Am J Surg Pathol; 2018 Apr; 42(4):553-560. PubMed ID: 29309307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive Nested Glomoid Neoplasm: Clinicopathologic Analysis of 20 Cases of a Mesenchymal Neoplasm With Frequent GLI1 Alterations and Indolent Behavior.
    Papke DJ; Dickson BC; Oliveira AM; Sholl LM; Fletcher CDM
    Am J Surg Pathol; 2023 Jan; 47(1):12-24. PubMed ID: 36395474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis.
    Kerr DA; Cloutier JM; Margolis M; Mata DA; Rodrigues Simoes NJ; Faquin WC; Dias-Santagata D; Chopra S; Charville GW; Wangsiricharoen S; Lazar AJ; Wang WL; Rosenberg AE; Tse JY
    Mod Pathol; 2024 Feb; 37(2):100386. PubMed ID: 37992966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions.
    Agaram NP; Zhang L; Sung YS; Singer S; Stevens T; Prieto-Granada CN; Bishop JA; Wood BA; Swanson D; Dickson BC; Antonescu CR
    Mod Pathol; 2019 Nov; 32(11):1617-1626. PubMed ID: 31189998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head and Neck Mesenchymal Neoplasms With GLI1 Gene Alterations: A Pathologic Entity With Distinct Histologic Features and Potential for Distant Metastasis.
    Xu B; Chang K; Folpe AL; Kao YC; Wey SL; Huang HY; Gill AJ; Rooper L; Bishop JA; Dickson BC; Lee JC; Antonescu CR
    Am J Surg Pathol; 2020 Jun; 44(6):729-737. PubMed ID: 31934916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLI1-Altered Soft Tissue Tumors of the Head and Neck: Frequent Oropharyngeal Involvement, p16 Immunoreactivity, and Detectable Alterations by DDIT3 Break Apart FISH.
    Palsgrove DN; Rooper LM; Stevens TM; Shin C; Damm DD; Gagan J; Bridge JA; Thompson LDR; Koduru PR; Bishop JA
    Head Neck Pathol; 2022 Dec; 16(4):1146-1156. PubMed ID: 35933574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLI1 -Rearranged Enteric Tumor : Expanding the Spectrum of Gastrointestinal Neoplasms With GLI1 Gene Fusions.
    Jessurun J; Orr C; McNulty SN; Hagen CE; Alnajar H; Wilkes D; Kudman S; Al Assaad M; Dorsaint P; Ohara K; He F; Chiu K; Yin YM; Xiang JZ; Qin L; Sboner A; Elemento O; Yantiss RK; Graham RP; Poizat F; Mosquera JM
    Am J Surg Pathol; 2023 Jan; 47(1):65-73. PubMed ID: 35968961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLI1-altered epithelioid soft tissue tumor: A newly described entity with a predilection for the tongue.
    Zhong H; Xu C; Chen X; Guo X; Yang S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jul; 134(1):e14-e22. PubMed ID: 35165054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial GLI1-amplified mesenchymal neoplasms: Expanding the spectrum of an emerging entity which reaches the realm of dermatopathology.
    Machado I; Hosler GA; Traves V; Claramunt R; Sanmartín O; Santonja C; Carvajal N; Zazo S; Requena L; Alfonso VS; Domenech EV; Llombart-Bosch A; Bridge JA; Linos K
    J Cutan Pathol; 2023 Jun; 50(6):487-499. PubMed ID: 36316249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLI1-altered Mesenchymal Tumor Involving the Duodenum: Case Report and Literature Review.
    Zeng Y; Yao H; Jiang X; Tang X; Wang X
    Int J Surg Pathol; 2023 Dec; 31(8):1538-1547. PubMed ID: 36855297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelioid Soft Tissue Neoplasm of the Soft Palate with a PTCH1-GLI1 Fusion: A Case Report and Review of the Literature.
    Klubíčková N; Kinkor Z; Michal M; Baněčková M; Hájková V; Michálek J; Pink R; Dvořák Z; Michal M; Leivo I; Skálová A
    Head Neck Pathol; 2022 Jun; 16(2):621-630. PubMed ID: 34655412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous epithelioid mesenchymal neoplasm with ACTB-GLI1 fusion: a case report.
    Rollins BT; Cassarino DS; Lindberg M
    J Cutan Pathol; 2022 Mar; 49(3):284-287. PubMed ID: 34643288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the spectrum of GLI1-altered mesenchymal tumors-A high-grade uterine sarcoma harboring a novel PAMR1::GLI1 fusion and literature review of GLI1-altered mesenchymal neoplasms of the gynecologic tract.
    Punjabi LS; Goh CHR; Sittampalam K
    Genes Chromosomes Cancer; 2023 Feb; 62(2):107-114. PubMed ID: 36222065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics.
    Parrack PH; Mariño-Enríquez A; Fletcher CDM; Hornick JL; Papke DJ
    Am J Surg Pathol; 2023 Apr; 47(4):453-460. PubMed ID: 36693363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pericytoma With t(7;12) and ACTB-GLI1 Fusion: Reevaluation of an Unusual Entity and its Relationship to the Spectrum of GLI1 Fusion-related Neoplasms.
    Kerr DA; Pinto A; Subhawong TK; Wilky BA; Schlumbrecht MP; Antonescu CR; Nielsen GP; Rosenberg AE
    Am J Surg Pathol; 2019 Dec; 43(12):1682-1692. PubMed ID: 31567194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Clinicopathologic and Molecular Reappraisal of GLI1-altered Mesenchymal Tumors with Pooled Outcome Analysis Showing Poor Survival in GLI1- amplified Versus GLI1-rearranged Tumors.
    Saoud C; Agaimy A; Dermawan JK; Chen JF; Rosenblum MK; Dickson BC; Dashti N; Michal M; Kosemehmetoglu K; Din NU; Albritton K; Agaram NP; Antonescu CR
    Am J Surg Pathol; 2024 Jun; ():. PubMed ID: 38934567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms.
    Machado I; Agaimy A; Giner F; Navarro S; Michal M; Bridge J; Claramunt R; López-Guerrero JA; Alcacer J; Linos K; Llombart-Bosch A
    Virchows Arch; 2024 May; 484(5):765-775. PubMed ID: 37940743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLI1-Altered Mesenchymal Tumors.
    Cloutier JM; Kerr DA
    Surg Pathol Clin; 2024 Mar; 17(1):13-24. PubMed ID: 38278602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique case of a
    Godse NR; Alsulaimani S; Singh AD; Fletcher CD; Astbury C; Fritchie K; Recinos PF; Sindwani R
    Orbit; 2023 Jun; ():1-5. PubMed ID: 37345250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.